ACB Earnings

ACB reported its earnings on 2026-02-04, showcasing a revenue of 67.57M against an estimate of 65.92M, resulting in a 2.5% surprise. The EPS was 0.09, surpassing the expected 0 by 0%. The stock experienced a -7.64% price change on the earnings day and a -11.58% change over the next five days, reflecting market reactions to the results.

Following ACB's earnings announcement on 2026-02-04, the stock price moved by -7.64% on the day of the release. Over the subsequent five days, it saw a -11.58% change. Historically, ACB's stock price tends to shift by an average of 2.15% in the 10 days leading up to earnings and -3.05% in the 10 days following, providing insight into potential market.

For 2026/Q4, analysts estimate ACB's annual revenue to reach 98.95M, while the EPS is projected at . These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between ACB's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2026 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, ACB's stock price typically moves by 2.15% in the 10 days before its earnings and -3.05% in the 10 days after. For the upcoming 2026/Q4 earnings, analysts expect an EPS of and revenue of 98.95M.

The earnings call summary suggests a mix of positive and neutral aspects. Positive factors include strong financial performance and strategic focus on profitable segments like global medical cannabis. However, uncertainties such as the exit from plant propagation, lack of specific timelines, and unclear management responses regarding revenue deceleration create a balanced outlook. The Q&A section did not reveal significant risks but highlighted strategic shifts and market exploration. Overall, the sentiment appears neutral due to the balanced nature of positive growth strategies and uncertainties in execution and market conditions.